• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.

作者信息

Testa R, Grasso A, Dagnino F, Ibba R, Varagona G, Celle G

出版信息

Br J Clin Pharmacol. 1987 Jun;23(6):779-80.

PMID:2886146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1386177/
Abstract
摘要

相似文献

1
Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.法莫替丁不影响健康受试者体内吲哚菁绿的代谢及血清胆汁酸水平。
Br J Clin Pharmacol. 1987 Jun;23(6):779-80.
2
Effect of famotidine on hepatic hemodynamics and peptic ulcer.法莫替丁对肝脏血流动力学及消化性溃疡的影响。
Am J Gastroenterol. 1987 May;82(5):415-8.
3
A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.法莫替丁和西咪替丁对苯妥英钠消除及肝血流量影响的比较。
Br J Clin Pharmacol. 1989 Jan;27(1):83-7. doi: 10.1111/j.1365-2125.1989.tb05338.x.
4
Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
Clin Ther. 1987;9(5):528-35.
5
[Negative inotropic action of famotidine].[法莫替丁的负性肌力作用]
Schweiz Med Wochenschr. 1988 Dec 17;118(50):1912-4.
6
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].
Arzneimittelforschung. 1984;34(9):1041-2.
7
Effect of famotidine on theophylline clearance in asthma and COPD patients.
Arerugi. 1987 Nov;36(11):1012-7.
8
[Effects of famotidine on plasma pentazocine concentration in surgical patients].
Masui. 1988 Jun;37(6):701-6.
9
[Action of famotidine, a new H2-receptor antagonist, on the papillary muscle and atrium of the guinea pig, in vitro].[新型H2受体拮抗剂法莫替丁对豚鼠乳头肌和心房的体外作用]
Cardiologia. 1987 Sep;32(9):1025-9.
10
Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide.
Anticancer Res. 1988 Nov-Dec;8(6):1241-5.

引用本文的文献

1
Whole-Blood Taurine Concentrations in Cats With Intestinal Disease.患有肠道疾病的猫的全血牛磺酸浓度
J Vet Intern Med. 2017 Jul;31(4):1067-1073. doi: 10.1111/jvim.14773. Epub 2017 Jun 19.
2
Haematological adverse effects of histamine H2-receptor antagonists.组胺H2受体拮抗剂的血液学不良反应。
Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):430-48. doi: 10.1007/BF03259895.
3
Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.新型H2受体拮抗剂。临床药代动力学及药物相互作用潜力。
Clin Pharmacokinet. 1988 Oct;15(4):205-15. doi: 10.2165/00003088-198815040-00001.
4
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.法莫替丁。对其药效学和药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗用途的最新综述。
Drugs. 1989 Oct;38(4):551-90. doi: 10.2165/00003495-198938040-00005.
5
A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.法莫替丁和西咪替丁对苯妥英钠消除及肝血流量影响的比较。
Br J Clin Pharmacol. 1989 Jan;27(1):83-7. doi: 10.1111/j.1365-2125.1989.tb05338.x.
6
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学（第二部分）。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
7
Clinical pharmacokinetics of famotidine.法莫替丁的临床药代动力学。
Clin Pharmacokinet. 1991 Sep;21(3):178-94. doi: 10.2165/00003088-199121030-00003.

本文引用的文献

1
SPECTROPHOTOMETRIC DETERMINATION OF INDOCYANINE GREEN IN PLASMA ESPECIALLY WITH A VIEW TO AN IMPROVED CORRECTION FOR BLANK DENSITY.
Scand J Clin Lab Invest. 1963;15:613-21. doi: 10.3109/00365516309051344.
2
Half-life time or clearance of indocyanine green in patients with liver disease.
Hepatogastroenterology. 1982 Apr;29(2):55-7.
3
Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.狒狒和人类中吲哚菁绿肝摄取的清除率及非侵入性测定
Clin Sci (Lond). 1983 Feb;64(2):207-12. doi: 10.1042/cs0640207.
4
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid.
Eur J Clin Invest. 1980 Aug;10(4):261-71. doi: 10.1111/j.1365-2362.1980.tb00032.x.
5
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.法莫替丁和西咪替丁对健康志愿者安替比林代谢动力学的比较效应。
Br J Clin Pharmacol. 1984 Jul;18(1):105-6. doi: 10.1111/j.1365-2125.1984.tb05031.x.
6
Serum bile acid determination after different doses of orally ingested chenodeoxycholic acid. Evaluation of a simplified enzymatic method.
Scand J Gastroenterol. 1985 Dec;20(10):1221-6. doi: 10.3109/00365528509089280.
7
Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function.
J Hepatol. 1985;1(6):609-17. doi: 10.1016/s0168-8278(85)80004-0.
8
Effect of famotidine on oxidative drug metabolism.法莫替丁对药物氧化代谢的影响。
Eur J Clin Pharmacol. 1986;30(3):279-81. doi: 10.1007/BF00541528.
9
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.法莫替丁，一种新型H2受体拮抗剂，不影响地西泮的肝脏清除或普鲁卡因胺的肾小管分泌。
Eur J Clin Pharmacol. 1985;28(6):671-5. doi: 10.1007/BF00607913.